ETC-1002
1002-005
Phase 2 small_molecule completed
Quick answer
ETC-1002 for Hyperlipidemia is a Phase 2 program (small_molecule) at Esperion Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Esperion Therapeutics
- Indication
- Hyperlipidemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed